Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen Utikal
Selma Ugurel

Showing results (271-280 of 490) with videos related to

Pageof 49
Sort By:
Oncotarget|May 17, 2018
<i>MYC</i> gene amplification is a rare event in atypical fibroxanthoma and pleomorphic dermal sarcomaTimo Gaiser, Daniela Hirsch, Azadeh Orouji, et al.
Clinical Chemistry|February 28, 2018
Liquid Profiling of Circulating Tumor DNA in Plasma of Melanoma Patients for Companion Diagnostics and Monitoring of BRAF Inhibitor TherapyVerena Haselmann, Christoffer Gebhardt, Ingrid Brechtel, et al.
Nature|August 12, 2009
Immortalization eliminates a roadblock during cellular reprogramming into iPS cellsJochen Utikal, Jose M Polo, Matthias Stadtfeld, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 15, 2016
T-Cell Therapy Enabling Adenoviruses Coding for IL2 and TNFα Induce Systemic Immunomodulation in Mice With Spontaneous MelanomaSiri Tähtinen, Carolin Blattner, Markus Vähä-Koskela, et al.
Cancer Immunology, Immunotherapy : CII|May 26, 2018
T-lymphocyte profiles differ between keratoacanthomas and invasive squamous cell carcinomas of the human skinCorinne Bauer, Ashik Ahmed Abdul Pari, Viktor Umansky, et al.
Eneurologicalsci|February 19, 2021
Detect it so you can treat it: A case series and proposed checklist to detect neurotoxicity in checkpoint therapySaskia Bolz, Thivyah Ramakrishnan, Michael Fleischer, et al.
European Radiology|May 1, 2025
Adverse effects of systemic advanced melanoma therapies-do BRAF/MEK inhibitors increase the incidence of mesenteric panniculitis?Marcel Alexander Drews, Alexander Baumgarten, Sebastian Zensen, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 14, 2021
Carl Maximilian Thielmann, Selma Ugurel, Elisabeth Livingstone, et al.
European Journal of Cancer (Oxford, England : 1990)|August 15, 2021
The concepts of rechallenge and retreatment with immune checkpoint blockade in melanoma patientsAnne Zaremba, Alexander M M Eggermont, Caroline Robert, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 24, 2021
Metastatic pigmented epithelioid melanocytoma in a 7-year-old femaleCarl Maximilian Thielmann, Selma Ugurel, Elisabeth Livingstone, et al.
Pageof 49

Showing results (271-280 of 490) with videos related to

Sort By:
Pageof 49
Oncotarget|May 17, 2018
<i>MYC</i> gene amplification is a rare event in atypical fibroxanthoma and pleomorphic dermal sarcomaTimo Gaiser, Daniela Hirsch, Azadeh Orouji, et al.
Clinical Chemistry|February 28, 2018
Liquid Profiling of Circulating Tumor DNA in Plasma of Melanoma Patients for Companion Diagnostics and Monitoring of BRAF Inhibitor TherapyVerena Haselmann, Christoffer Gebhardt, Ingrid Brechtel, et al.
Nature|August 12, 2009
Immortalization eliminates a roadblock during cellular reprogramming into iPS cellsJochen Utikal, Jose M Polo, Matthias Stadtfeld, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 15, 2016
T-Cell Therapy Enabling Adenoviruses Coding for IL2 and TNFα Induce Systemic Immunomodulation in Mice With Spontaneous MelanomaSiri Tähtinen, Carolin Blattner, Markus Vähä-Koskela, et al.
Cancer Immunology, Immunotherapy : CII|May 26, 2018
T-lymphocyte profiles differ between keratoacanthomas and invasive squamous cell carcinomas of the human skinCorinne Bauer, Ashik Ahmed Abdul Pari, Viktor Umansky, et al.
Eneurologicalsci|February 19, 2021
Detect it so you can treat it: A case series and proposed checklist to detect neurotoxicity in checkpoint therapySaskia Bolz, Thivyah Ramakrishnan, Michael Fleischer, et al.
European Radiology|May 1, 2025
Adverse effects of systemic advanced melanoma therapies-do BRAF/MEK inhibitors increase the incidence of mesenteric panniculitis?Marcel Alexander Drews, Alexander Baumgarten, Sebastian Zensen, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 14, 2021
Carl Maximilian Thielmann, Selma Ugurel, Elisabeth Livingstone, et al.
European Journal of Cancer (Oxford, England : 1990)|August 15, 2021
The concepts of rechallenge and retreatment with immune checkpoint blockade in melanoma patientsAnne Zaremba, Alexander M M Eggermont, Caroline Robert, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 24, 2021
Metastatic pigmented epithelioid melanocytoma in a 7-year-old femaleCarl Maximilian Thielmann, Selma Ugurel, Elisabeth Livingstone, et al.
Pageof 49